Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 1248Neoplasms 1053Carcinoma, Non-Small-Cell Lung 861Prostatic Neoplasms 703Colorectal Neoplasms 618Lung Neoplasms 586Neoplasm Metastasis 446Multiple Myeloma 427Leukemia, Myeloid, Acute 403Pancreatic Neoplasms 377Ovarian Neoplasms 370Melanoma 324Carcinoma, Hepatocellular 293Recurrence 282Squamous Cell Carcinoma of Head and Neck 277Brain Neoplasms 274Glioblastoma 251Head and Neck Neoplasms 249Stomach Neoplasms 239Carcinoma, Renal Cell 231Precursor Cell Lymphoblastic Leukemia-Lymphoma 230Lymphoma 229Triple Negative Breast Neoplasms 219Hematologic Neoplasms 214Endometrial Neoplasms 213Urinary Bladder Neoplasms 202Lymphoma, Non-Hodgkin 198Uterine Cervical Neoplasms 194Sarcoma 192Glioma 190

Interventions

liposomal doxorubicin 1Zidovudine 1Vincristine 1Valganciclovir 1Sirolimus 1Rituximab 1Prednisone 1Interferon-alpha 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Macular dystrophy, corneal type 1 × 90 days × Clear all
NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡